Proteoforms of the SARS-CoV-2 nucleocapsid protein are primed to proliferate the virus and attenuate the antibody response (2020)

First Author: Lutomski C

Attributed to: Applications of Mass Spectrometry to Membrane Protein Drug Development funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.10.06.328112

Publication URI: http://dx.doi.org/10.1101/2020.10.06.328112

Type: Preprint